SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: zx who wrote (180)1/15/1998 11:30:00 AM
From: targetedmoab  Respond to of 656
 
Micheal,
Enbrel should be at the FDA for review by the end of the 2nd quarter. If its expidited, it should take up to six months for approval. Hopefully it should be on the market by the end of the year,